Introduction
Pathogenic free-living amoebae including Acanthamoeba spp., Naegleria fowleri and Balamuthia mandrillaris cause infection of central nervous system (CNS) and have a mortality rate of greater than 95%. [1] These infections have been described in both immunocompetent and immunocompromised individuals. [1] [2] [3] [4] The main predisposing factors are skin lesions, diabetes mellitus, liver cirrhosis, antineoplastic therapy and human immunodeficiency virus (HIV). [1, 4] While N. fowleri causes primary amoebic meningoencephalitis that is rapidly fatal, Acanthamoeba and B. mandrillaris cause encephalitis which has a subacute or chronic and insidious course. [2, 3] Infection usually manifests clinically as progressive headache, fever, abnormalities of higher mental functions, hemiparesis, cranial nerve palsies, seizures. [4] As a result of such varied manifestations, it is often confused with other infectious conditions like tuberculosis, abscesses, toxoplasmosis or non-infectious conditions like malignancy. [5] Hence, a majority of the cases are diagnosed postmortem at autopsy by identification of amoebic trophozoites or cysts on histopathology and confirmed by immunofluorescence or polymerase chain reaction (PCR). [1, 3, 6] However, ante-mortem diagnosis by histopathological examination and culture plays a very important role. It is difficult to grow Balamuthia in vitro, thus molecular tests play a very important role.
Here, we report two cases of granulomatous amoebic encephalitis (GAE), one of which was diagnosed ante-mortem and one postmortem by using PCR that targeted the 16s region of B. mandrillaris, followed by and vancomycin were added to the pre-existing regimen. However, the patient deteriorated further and succumbed to his illness on 5 January 2013. Autopsy of the brain showed multiple variable-sized haemorrhagic and necrotic lesions and granulomas with trophozoites in large numbers in frontal and parietal lobes, insula, corpus callosum and left cerebellum [ Figures 1 and 2 ]. PCR on these sections was positive for Balamuthia mandrillaris and negative for Acanthamoeba spp [ Figure 3 ].
Case 2
An 18-year-old previously healthy male presented to PGIMER on 1 May 2013 with history of headache for diplopia for 15 days, fever and vomiting for 1 week. He was apparently healthy 1 month prior to developing progressive holocranial throbbing headache, which was more severe in the morning and associated with head banging. The patient had raised intracranial pressure at admission, thus lumbar puncture was not performed. The computed tomography (CT) scan demonstrated the presence of oedema in the right and left high parafalcine regions suggesting cerebritis phase of TB. The patient was started on ATT. Two weeks later, he developed binocular diplopia, continuous fever and projectile vomiting. MRI scan showed presence of ill-defined lesions of varying sizes and intensity in the left parafalcine, left high frontoparietal region, left parietooccipital and right high parietal region, the largest measuring 6.2 × 4.7 cm. These lesions were thought to be granulomatous in nature. Because of the increasing size and number of the lesions and appearance of new symptoms, debulking and biopsy of the intracerebral mass was performed which showed necrosis, granulomatous inflammation, amoebae and cysts. PCR on the fixed sections was positive for Balamuthia only. It was sequenced and had 100% identity with B. mandrillaris isolate V 433. The sequences were submitted to Genbank with accession numbers KF246746. The patient was then started on albendazole, amphotericin and clarithromycin. However, the patient continued to deteriorate and succumbed to his illness.
Outcome and follow-up
Both the patients succumbed to the illness; and in one case, diagnosis of Balamuthia meningoencephalitis was made postmortem.
Discussion
Here, we present two cases of Balamuthia mandrillaris GAE which were diagnosed by PCR. There is only one report from India prior to our report [9] though approximately 200 cases are reported worldwide. [1, [6] [7] [8] Diagnosis and treatment of GAE due to B. mandrillaris is particularly challenging because of the rarity of the disease, lack of awareness among both the clinicians and laboratory physicians and an inability to distinguish it clinically from neurotuberculosis, tuberculoma neurocysticercosis, other non-infectious aetiologies and from Acanthamoeba spp. on histopathology and inability to grow in culture medium. In such cases, early diagnosis by molecular methods should be recommended. We performed PCR using primers targeting 16s deoxyribonucleic acid (DNA) that yields a product of 1075bp of Balamuthia and 950bp of Acanthamoeba and followed it up with sequencing that gave 100% homology with B. mandrillaris. [7, 8] Balamuthia has been found in other organs including the kidneys, adrenal glands and lungs. [10] However, we did not find Balamuthia in organs other than brain in case 2, while case 1 was partial brain autopsy. The occurrence of two cases within a span of few months in immunocompetent individuals at our centre indicates the presence of this rare agent in this country and a need for increased awareness among both clinicians and laboratory physicians for adequate and timely diagnosis and management of patients.
